Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Long-long Gao"'
Publikováno v:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 47(22)
Oxidosqualene cyclases(OSCs), belonging to a multigene family, can convert a common precursor 2,3-oxidosqualene into various types of triterpene skeletons. In this study, primers were designed according to the analysis of Siraitia grosvenorii transcr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ce4c67bf80749e53754827cfdd95e1e
https://pubmed.ncbi.nlm.nih.gov/36471929
https://pubmed.ncbi.nlm.nih.gov/36471929
Autor:
Bernie D. Sattin, Yanli Wang, Dorota Dajnowiec, Kinda Karra, Cynthia H. Seow, Long-long Gao, Brian Bressler, Waqqas Afif, Reena Khanna, Martin Williamson
Publikováno v:
Digestive Diseases and Sciences. 67:3148-3157
The value of ustekinumab (UST) therapeutic drug monitoring (TDM) in clinical practice remains unclear. This study examined the impact of UST TDM on clinical decision making in patients with Crohn’s disease (CD). A total of 110 consecutive UST-treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d581f2d716fbc004b264b1f544b63a
https://doi.org/10.1007/s10620-021-07173-1
https://doi.org/10.1007/s10620-021-07173-1
Autor:
Harland S. Winter, Omoniyi J. Adedokun, Robert N. Baldassano, James Markowitz, Anne M. Griffiths, Elyssa Ott, Long-Long Gao, Tony Ma, Christopher Busse, Sibylle Koletzko, James L. Izanec, Subra Kugathasan, Christopher Gasink, Marla Dubinsky, Richard B. Colletti, Frank M. Ruemmele, Jeffrey S. Hyams
Publikováno v:
American Journal of Gastroenterology. 116:S592-S593
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67fc1e4344be4df93d0678ed78dc044e
https://doi.org/10.14309/01.ajg.0000778692.42211.5f
https://doi.org/10.14309/01.ajg.0000778692.42211.5f
Autor:
Stephen B. Hanauer, Oksana Shchukina, Matthieu Allez, Edward V. Loftus, Long-Long Gao, Andrew Greenspan, Remo Panaccione, Christopher Gasink, James D. Lewis, Silvio Danese, Bruce E. Sands, Emese Mihály, Timothy Hoops, J Izanec, Vipul Jairath, Peter M. Irving, Tanja Kuehbacher, William J. Sandborn, Ellen Scherl
Publikováno v:
Gastroenterology. 161:e30-e31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df404bc4b61d6be54b3fce9b9375bfcd
https://doi.org/10.1053/j.gastro.2021.06.040
https://doi.org/10.1053/j.gastro.2021.06.040
Autor:
Christopher Gasink, Long-Long Gao, Douglas Jacobstein, Brian G. Feagan, Stephan R. Targan, Bruce E. Sands, C. Han, William J. Sandborn, Philippe Szapary, Yinghua Lang
Publikováno v:
Journal of Crohn's and Colitis. 12:883-895
Background and Aims We assessed the effect of ustekinumab on health-related quality of life [HRQOL] in adults with Crohn's disease [CD]. Methods Patients with moderately to severely active CD and inadequate response or intolerance to tumour necrosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5c0a87af22b73867a5a92028c629a4
https://doi.org/10.1093/ecco-jcc/jjy055
https://doi.org/10.1093/ecco-jcc/jjy055
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease
Autor:
Stephen B. Hanauer, Omoniyi J. Adedokun, Christopher Gasink, Subrata Ghosh, Jewel Johanns, Zhenhua Xu, Philippe Szapary, Hugh M. Davis, William J. Sandborn, Long Long Gao, Douglas Jacobstein, Brian G. Feagan
Publikováno v:
Gastroenterology. 154:1660-1671
Background & Aims Ustekinumab is a monoclonal antibody that binds with high affinity to the p40 subunit of human interleukin 12 (IL12 and IL23) that has been approved for treatment of patients with moderate to severe Crohn's disease (CD). However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3026c4a872adf505fd73e248aede45e0
https://doi.org/10.1053/j.gastro.2018.01.043
https://doi.org/10.1053/j.gastro.2018.01.043
Autor:
A Greenspan, W J Sandborn, Mathieu Allez, O Shchukina, Remo Panaccione, Stephen B. Hanauer, Long-Long Gao, Tanja Kuehbacher, Ellen Scherl, Peter M. Irving, J Izanec, Bruce E. Sands, Christopher Gasink, Silvio Danese, Edward V. Loftus, Vipul Jairath, James D. Lewis, T Hoops, Emese Mihály
Publikováno v:
Journal of Crohn's and Colitis. 15:S001-S002
Background We studied the efficacy and safety of ustekinumab (UST) vs adalimumab (ADA) through 1 year in biologic-naïve patients (pts) with moderate-to-severe Crohn’s disease. Methods SEAVUE was a multicenter, randomized, blinded, parallel-group,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5f08709414e9d7ef636029cf2f562e8
https://doi.org/10.1093/ecco-jcc/jjab075.001
https://doi.org/10.1093/ecco-jcc/jjab075.001
Autor:
Erik Muser, James L. Izanec, Christopher Gasink, Long-Long Gao, Timothy Hoops, Zhijie Ding, Tony Ma
Publikováno v:
American Journal of Gastroenterology. 116:S330-S330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67b8fcb8f5652f1b784c16e6b9a32102
https://doi.org/10.14309/01.ajg.0000776424.66172.cb
https://doi.org/10.14309/01.ajg.0000776424.66172.cb
Autor:
Martin Williamson, Waqqas Afif, Bernie D. Sattin, Reena Khanna, Cynthia H. Seow, Dorota Dajnowiec, Long-Long Gao, K Karra, mUST-Decide, Brian Bressler
Publikováno v:
Journal of Crohn's and Colitis. 14:S443-S444
Background Therapeutic drug monitoring is an important adjunct in optimising IBD management in patients treated with anti-TNF therapies. However, it remains unclear whether these principles apply to non-anti-TNF biologic therapies, such as the anti-I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8d7227fdab4cc4c78eb4afdcd8d8a47
https://doi.org/10.1093/ecco-jcc/jjz203.640
https://doi.org/10.1093/ecco-jcc/jjz203.640
Autor:
Long-Long Gao, Dorota Dajnowiec, Martin Williamson, Cynthia H. Seow, Reena Khanna, Brian Bressler, Kinda Karra, Bernie D. Sattin, Waqqas Afif
Publikováno v:
Gastroenterology. 158:S-464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea79dd862ea41f7271318e81fef9c502
https://doi.org/10.1016/s0016-5085(20)31843-6
https://doi.org/10.1016/s0016-5085(20)31843-6